Interventional oncology in multidisciplinary cancer treatment in the 21 st century

Nature Reviews Clinical Oncology

Volumn 12, Issue 2, 2015, Pages 105-113

  Adam, Andreas ^a   Kenny, Lizbeth M ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CRYOTHERAPY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HYPERTHERMIC THERAPY; IMAGE GUIDED RADIOTHERAPY; IMAGE PROCESSING; INTERDISCIPLINARY COMMUNICATION; INTERVENTIONAL RADIOLOGY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; NEOPLASM; RADIATION ONCOLOGIST; RADIOFREQUENCY RADIATION; REVIEW; TREATMENT INDICATION; NEOPLASMS; ONCOLOGY; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; PATIENT CARE; PROCEDURES; TRENDS;

HUMANS; NEOPLASMS; PALLIATIVE CARE; PATIENT CARE TEAM; QUALITY ASSURANCE, HEALTH CARE; RADIATION ONCOLOGY; RADIOLOGY, INTERVENTIONAL;

EID: 84923125472     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2014.211     Document Type: Review

References (97)

1. Fairchild, A. et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J. Clin. Oncol. 26, 4001-4011 (2008).
2. Skladowski, K. et al. Randomized clinical trial on 7-day continuous accelerated irradiation (CAIR) of head and neck cancer-report on 3-year tumor control and normal tissue toxicity. Radiother. Oncol. 55, 101-110 (2000).
3. Rose, P. et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340, 1144-1153 (1999).
4. Kenny, L., Peters, L., Rodger, A., Barton, M. & Turner, S. Modern radiotherapy for modern surgeons: an update on radiation oncology. ANZ J. Surg. 72, 131-136 (2002).
5. Kenny, L. M., Peters, L. J., Barton, M. & Milross, C. Radiotherapy-a leap forward in cancer care. Cancer Forum 37, 42-46 (2013).
6. Coles, C. E., Moody, A. M., Wilson, C. B. & Burnet, N. G. Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part II-radiotherapy strategies to reduce radiation-induced late effects. Clin. Oncol. 17, 98-110 (2005).
7. Bucci, M. K., Bevan, A. & Roach, M. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J. Clin. 55, 117-134 (2005).
8. Delaney, G., Jacob, S., Featherstone, C. & Barton, M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104, 1129-1137 (2005).
9. Jacob, S., Wong, K., Delaney, G. P., Adams, P. & Barton, M. B. Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients. Clin. Oncol. (R. Coll. Radiol.) 22, 56-64 (2010).
10. Dotter, C. T. & Judkins, M. P. Transluminal treatment of arteriosclerotic obstruction: description of a new technic and a preliminary report of its application. Circulation 30, 654-670 (1964).
11. Molyneux, A. J. et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366, 809-817 (2005).
12. Katsanos, K. et al. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Cardiovasc. Intervent. Radiol. 37, 427-437 (2014).
13. Becker, G. J., Katzen, B. T. & Dake, M. D. Noncoronary angioplasty. Radiology 170, 921-940 (1989).
14. Chabbert, V. et al. Midterm outcomes of thoracic aortic stent-grafts: complications and imaging techniques. J. Endovasc. Ther. 10, 494-504 (2003).
15. García-Pagán, J. C. et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N. Engl. J. Med. 362, 2370-2379 (2010).
16. Kee, S. T. et al. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 206, 187-193 (1998).
17. Marcy, P. Y. et al. Superior vena cava obstruction: is stenting necessary? Support. Care Cancer 9, 103-107 (2001).
18. Nicholson, A. A., Ettles, D. F., Arnold, A., Greenstone, M. & Dyet, J. F. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J. Vasc. Interv. Radiol. 8, 781-788 (1997).
19. Rozenblit, A. et al. Endovascular repair of abdominal aortic aneurysm: value of postoperative follow-up with helical C T. AJR Am. J. Roentgenol. 165, 1473-1479 (1995).
20. Struk, D. W., Rankin, R. N., Eliasziw, M. & Vellet, A. D. Safety of outpatient peripheral angioplasty. Radiology 189, 193-196 (1993).
21. Swanson, K. L. et al. Bronchial artery embolization: experience with 54 patients. Chest 121, 789-795 (2002).
22. Uyeda, J. W., LeBedis, C. A., Penn, D. R., Soto, J. A. & Anderson, S. W. Active hemorrhage and vascular injuries in splenic trauma: utility of the arterial phase in multidetector C T. Radiology 270, 99-106 (2014).
23. Farrell, T. A. & Hicks, M. E. A review of radiologically guided percutaneous nephrostomies in 303 patients. J. Vasc. Interv. Radiol. 8, 769-774 (1997).
24. Bettmann, M. A., Perlmutt, L., Finkelstein, J., Meyerovitz, M. F. & Richie, J. P. Percutaneous placement of soft, indwelling ureteral stent. Radiology 157, 817-818 (1985).
25. Lang, E. K. et al. Placement of metallic stents in ureters obstructed by carcinoma of the cervix to maintain renal function in patients undergoing long-term chemotherapy. AJR Am. J. Roentgenol. 171, 1595-1599 (1998).
26. Van Arsdalen, K. N., Pollack, H. M. & Wein, A. J. Ureteral stenting. Semin. Urol. 2, 180-186 (1984).
27. Ferrucci, J. T., Mueller, P. R. & Harbin, W. P. Percutaneous transhepatic biliary drainage: technique, results and applications. Radiology 135, 1-13 (1980).
28. Mueller, P. R. et al. Biliary stent endoprostheses: analysis of complications in 113 patients. Radiology 156, 637-639 (1985).
29. Gibson, R. N. et al. Percutaneous transhepatic endoprosthesis for hilar cholangiocarcinoma. Am. J. Surg. 156, 363-367 (1988).
30. Adam, A., Yeung, E., Chetty, N., Roddie, M. & Benjamin, I. S. Self-expandable stainless steel endoprostheses for the treatment of malignant bile duct obstruction. AJR Am. J. Roentgenol. 156, 321-325 (1990).
31. Laméris, J. S. et al. Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology 179, 703-707 (1991).
32. McKeown, B. J., Wong, W. L. & Adam, A. True single-stage percutaneous insertion of Wallstent biliary endoprostheses. Minim. Invasive Ther. Allied Technol. 3, 257-260 (1994).
33. Stoker, J. & Lameris, J. S. Complications of percutaneously inserted biliary Wallstents. J. Vasc. Interv. Radiol. 4, 767-772 (1993).
34. van Delden, O. M. & Lameris, J. S. Percutaneous biliary drainage and stenting for palliation of malignant bile duct obstruction. Eur. Radiol. 18, 448-456 (2008).
35. Dumonceau, J. M. et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 44, 277-298 (2012).
36. Adam, A. et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 202, 344-348 (1997).
37. Adam, A., Morgan, R., Ellul, J. & Mason, R. C. A new design of the esophageal Wallstent endoprosthesis resistant to distal migration. AJR Am. J. Roentgenol. 170, 1477-1481 (1998).
38. Song, H. Y. et al. Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology 193, 689-695 (1994).
39. Watkinson, A. F., Ellul, J., Entwisle, K., Mason, R. C. & Adam, A. Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses. Radiology 195, 821-827 (1995).
40. Ellul, J., Watkinson, A. F., Khan, R., Adam, A. & Mason, R. C. Self-expandable metal stents for the palliation of dysphagia due to inoperable oesophageal carcinoma. Br. J. Surg. 82, 1678-1681 (1995).
41. Saxon, R. R. et al. Malignant esophageal obstruction and esophagorespiratory fistula: palliation with a polyethylene-covered Z-stent. Radiology 202, 349-354 (1997).
42. Costamagna, G. et al. Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surg. Endosc. 17, 891-895 (2003).
43. May, A., Hahn, E. G. & Ell, C. Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. J. Clin. Gastroenterol. 22, 261-266 (1996).
44. Cheung, H. Y. & Chung, S. C. Covered metal stent for tumor obstruction of efferent loop recurrence after gastrectomy. Surg. Endosc. 11, 936-938 (1997).
45. Pinto, I. T. Malignant gastric and duodenal stenosis: palliation by peroral implantation of a self-expanding metallic stent. Cardiovasc. Intervent. Radiol. 20, 431-434 (1997).
46. Yates, M. R., Morgan, D. E. & Baron, T. H. Palliation of malignant gastric and small intestinal strictures with self-expanding metal stents. Endoscopy 30, 266-272 (1998).
47. Binkert, C. A., Jost, R., Steiner, A. & Zollikofer, C. L. Benign and malignant stenoses of the stomach and duodenum: treatment with self-expanding metallic endoprostheses. Radiology 199, 335-338 (1996).
48. Ruiz, P. L. et al. New intraluminal bypass tube for management of acutely obstructed left colon. Dis. Colon Rectum 38, 1108-1109 (1995).
49. Rousseau, H. et al. Self-expandable prostheses in the tracheobronchial tree. Radiology 188, 199-203 (1993).
50. Inchingolo, R. et al. Tracheobronchial stenting for malignant airway disease: long-term outcomes from a single-center study. Am. J. Hosp. Palliat. Care 30, 683-689 (2013).
51. Goldberg, S. N., Gazelle, G. S., Compton, C. C., Mueller, P. R. & Tanabe, K. K. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88, 2452-2463 (2000).
52. Narayanan, G. Irreversible electroporation for treatment of liver cancer. Gastroenterol. Hepatol. 7, 313-316 (2011).
53. Lee, E. W. et al. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255, 426-433 (2010).
54. Liang, P. et al. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. J. Urol. 180, 844-848 (2008).
55. Cannon, R., Ellis, S., Hayes, D., Narayanan, G. & Martin, R. C. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J. Surg. Oncol. 107, 544-549 (2013).
56. Brace, C. L. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr. Probl. Diagn. Radiol. 38, 135-143 (2009).
57. Breen, D. J. et al. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. BJU Int. 112, 758-765 (2013).
58. Olweny, E. O. et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur. Urol. 61, 1156-1161 (2012).
59. Takaki, H. et al. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology 270, 292-299 (2014).
60. Ferakis, N., Bouropoulos, C., Granitsas, T., Mylona, S. & Poulias, I. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J. Endourol. 24, 1909-1913 (2010).
61. Psutka, S. P. et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur. Urol. 63, 486-492 (2013).
62. Krokidis, M. et al. Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results. Eur. Radiol. 23, 1933-1939 (2013).
63. Hur, H. et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am. J. Surg. 197, 728-736 (2009).
64. Elias, D. et al. Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur. J. Surg. Oncol. 26, 763-769 (2000).
65. Pawlik, T. M. et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann. Surg. Oncol. 10, 1059-1069 (2003).
66. Leung, E. Y., Roxburgh, C. S., Leen, E. & Horgan, P. G. Combined resection and radiofrequency ablation for bilobar colorectal cancer liver metastases. Hepatogastroenterology 57, 41-46 (2010).
67. 90Y microspheres (TheraSphere): safety, tumor response, and survival. J. Vasc. Interv. Radiol. 16, 1627-1639 (2005).
68. 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48, 333-337 (2001).
69. Sharma, R. A. et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J. Clin. Oncol. 25, 1099-1106 (2007).
70. Stuart, K. Chemoembolization in the management of liver tumors. Oncologist 8, 425-437 (2003).
71. de Baere, T. et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240, 587-596 (2006).
72. Simon, C. J. et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243, 268-275 (2007).
73. Yasui, K. et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 231, 850-857 (2004).
74. Gadaleta, C. et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am. J. Roentgenol. 183, 361-368 (2004).
75. Wolf, F. J. et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 247, 871-879 (2008).
76. Wang, H. et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 235, 289-298 (2005).
77. Rawlins, M. De Testimonio: on the evidence for decisions about the use of therapeutic interventions. Clin. Med. 8, 579-588 (2008).
78. Lassen, K., Høye A. & Myrmel, T. Randomised trials in surgery: the burden of evidence. Rev. Recent Clin. Trials 7, 244-248 (2012).
79. Scott, I. A. Comparative effectiveness research-the missing link in evidence-informed clinical medicine and health care policy making. Med. J. Aust. 198, 310-312 (2013).
80. Ahmed, M. et al. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. J. Vasc. Interv. Radiol. 16, 1365-1371 (2005).
81. Jin, Y. et al. Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes. J. Surg. Oncol. 106, 322-326 (2012).
82. Williamson, J. F. et al. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology". Int. J. Radiat. Oncol. Biol. Phys. 71 (Suppl.), S2-S12 (2008).
83. The Faculty of Radiation Oncology (FRO), The Royal Australian and New Zealand College of Radiologists (RANZCR), Australian Institute of Radiography (AIR), & The Australasian College of Physical Scientists and Engineers in Medicine (ASPSEM). Radiation Oncology Practice Standards [online], http://www.radiationoncology.com.au/supporting-docs/ranzcr-standards.pdf (2011).
84. Radiation Oncology Practice Standards. Supplementary guide [online], http://www.radiationoncology.com.au/supporting-docs/ranzcr-standardsguide.pdf (2011).
85. Peters, L. J. et al. Critical Impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J. Clin. Oncol. 28, 2996-3001 (2010).
86. Crocetti, L., de Baere, T. & Lencioni, R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc. Intervent. Radiol. 33, 11-17 (2010).
87. Rendon, R. A. et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J. Urol. 167, 1587-1592 (2002).
88. Loo, B. W. Stereotactic ablative radiotherapy (SABR) for lung cancer: what does the future hold? J. Thorac. Dis. 3, 150-152 (2011).
89. Haasbeek, C. J., Lagerwaard, F. J., Slotman, B. J. & Senan, S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J. Thorac. Oncol. 6, 2036-2043 (2011).
90. Senthi, S., Lagerwaard, F. J., Haasbeek, C. J., Slotman, B. J. & Senan, S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol. 13, 802-809 (2012).
91. Senthi, S., Haasbeek, C. J., Slotman, B. J. & Suneth, S. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiother. Oncol. 106, 276-282 (2013).
92. Dupuy, D. E. Radiofrequency ablation followed by conventional radiotherapy for medically noperable stage I non-small cell lung cancer. Chest 129, 738-745 (2006).
93. Jain, S. K., Dupuy, D. E., Cardarelli, G. A., Zheng, Z. & DiPetrillo, T. A. Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. AJR Am. J. Roentgenol. 181, 711-755 (2003).
94. Dawson, L. A. & Jaffray, D. A. Advances in mage-guided radiation therapy. J. Clin. Oncol. 8, 938-946 (2007).
95. Zietman, A. Image-targeted oncology: a 21st century specialty waiting to be born. Presented at The Royal College of Radiologists Clinical Oncology Annual Meeting 2013.
96. RCR. The Royal College of Radiologists [online], www.rcr.ac.uk (2014).
97. RANZCR. The Royal Australian and New Zealand College of Radiologists [online], www.ranzcr.edu.au (2014).